Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/SB-258719> ?p ?o }
Showing triples 1 to 63 of
63
with 100 triples per page.
- SB-258719 abstract "SB-258719 is a drug developed by GlaxoSmithKline which acts as a selective 5-HT7 receptor partial inverse agonist, and was the first such ligand identified for 5-HT7. Its use in research has mainly been in demonstrating the potential use for 5-HT7 agonists as potential novel analgesics, due to the ability of SB-258719 to block the analgesic effects of a variety of 5-HT7 agonists across several different testing models.".
- SB-258719 casNumber "195199-95-2".
- SB-258719 iupacName "(1R)-3,N-dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide".
- SB-258719 pubchem "5312148".
- SB-258719 thumbnail SB-258719_structure.png?width=300.
- SB-258719 wikiPageID "33046484".
- SB-258719 wikiPageLength "4781".
- SB-258719 wikiPageOutDegree "8".
- SB-258719 wikiPageRevisionID "667224580".
- SB-258719 wikiPageWikiLink 5-HT7.
- SB-258719 wikiPageWikiLink 5-HT7_receptor.
- SB-258719 wikiPageWikiLink Analgesic.
- SB-258719 wikiPageWikiLink Category:5-HT7_antagonists.
- SB-258719 wikiPageWikiLink Category:Piperidines.
- SB-258719 wikiPageWikiLink Category:Sulfonamides.
- SB-258719 wikiPageWikiLink GlaxoSmithKline.
- SB-258719 wikiPageWikiLink Inverse_agonist.
- SB-258719 wikiPageWikiLink Receptor_(biochemistry).
- SB-258719 wikiPageWikiLinkText "SB-258719".
- SB-258719 c "18".
- SB-258719 casNumber "195199".
- SB-258719 chembl "12264".
- SB-258719 chemspiderid "4471578".
- SB-258719 h "32".
- SB-258719 hasPhotoCollection SB-258719.
- SB-258719 inchi "1".
- SB-258719 inchikey "AGVNHDNTFYHZNL-QGZVFWFLBI".
- SB-258719 iupacName "-3".
- SB-258719 iupharLigand "281".
- SB-258719 molecularWeight "340.523".
- SB-258719 n "2".
- SB-258719 o "2".
- SB-258719 pubchem "5312148".
- SB-258719 s "1".
- SB-258719 smiles "c1ccccc1S[NH2]CCCNCCC2C".
- SB-258719 stdinchi "1".
- SB-258719 stdinchikey "AGVNHDNTFYHZNL-QGZVFWFLSA-N".
- SB-258719 verifiedfields "changed".
- SB-258719 verifiedrevid "477856143".
- SB-258719 width "220".
- SB-258719 wikiPageUsesTemplate Template:Drugbox.
- SB-258719 wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- SB-258719 wikiPageUsesTemplate Template:Reflist.
- SB-258719 wikiPageUsesTemplate Template:Serotonergics.
- SB-258719 subject Category:5-HT7_antagonists.
- SB-258719 subject Category:Piperidines.
- SB-258719 subject Category:Sulfonamides.
- SB-258719 hypernym Drug.
- SB-258719 type ChemicalSubstance.
- SB-258719 type Drug.
- SB-258719 type ChemicalObject.
- SB-258719 type Thing.
- SB-258719 type Q8386.
- SB-258719 comment "SB-258719 is a drug developed by GlaxoSmithKline which acts as a selective 5-HT7 receptor partial inverse agonist, and was the first such ligand identified for 5-HT7. Its use in research has mainly been in demonstrating the potential use for 5-HT7 agonists as potential novel analgesics, due to the ability of SB-258719 to block the analgesic effects of a variety of 5-HT7 agonists across several different testing models.".
- SB-258719 label "SB-258719".
- SB-258719 sameAs m.0h54m8g.
- SB-258719 sameAs SB-258,719.
- SB-258719 sameAs SB-258,719.
- SB-258719 sameAs Q855345.
- SB-258719 sameAs Q855345.
- SB-258719 wasDerivedFrom SB-258719?oldid=667224580.
- SB-258719 depiction SB-258719_structure.png.
- SB-258719 isPrimaryTopicOf SB-258719.